Rigosertib sodium T5818
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Rigosertib, a non-ATP-competitive inhibitor of PLK1(IC50=9 nM), exhibits 30-fold higher specificity activity over Plk2 and no effect on Plk3.
CAS nr:
592542-60-4
Purity:
98%
Molecular Weight:
473,47
SMILES:
COc1c(cc(cc1)CS(=O)(=O)/C=C/c1c(cc(cc1OC)OC)OC)NCC(=O)[O-].[Na+]
Formula:
C21H24NNaO8S
Pathway:
PI3K/Akt/mTOR signaling,Cell Cycle/Checkpoint,Apoptosis
Target:
PI3K,PLK,Apoptosis
